This inventor holds 42 USPTO granted patents and 19 published patent applications, plus 1 CIPO patent and 19 EPO patents, primarily in Endothelial Lipase Inhibitors. Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Squibb Pharma Company, Bristol Meyers Squibb Company. Active years: 2005-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lawrenceville, NJ (US) (2006)
- Princeton, NJ (US) (2005 - 2019)
Company Filing History:
37 out of 3,742 
4 out of 234 
1 out of 41 Years Active: 2005-2019
Areas of Expertise:
Title: Innovations by Jennifer X Qiao: A Leader in Endothelial Lipase Inhibition
Introduction
Jennifer X Qiao, based in Princeton, NJ, has carved a significant niche in the field of medicinal chemistry with an impressive portfolio of 42 patents. Her innovative work primarily focuses on developing compounds that serve as inhibitors of endothelial lipase, a crucial target for medications aimed at managing lipid levels in the body.
Latest Patents
Among her latest patents, Qiao has contributed to the development of sulfone amide linked benzothiazole inhibitors of endothelial lipase. These compounds are outlined in her specification as Formula (I) and hold potential as effective medicaments. Furthermore, she has also worked on antagonists of the P2Y receptor, which may also serve as valuable pharmaceutical agents. The specificity of these compounds highlights her expertise and innovative approach to drug discovery.
Career Highlights
Jennifer has had a notable career, particularly during her tenure at Bristol-Myers Squibb Company and Bristol-Myers Squibb Pharma Company. Her contributions have significantly advanced the understanding and treatment options available for conditions linked to lipid metabolism.
Collaborations
Throughout her career, Qiao has collaborated with esteemed colleagues, including Tammy C Wang and Zulan Pi. These partnerships have been instrumental in driving forward groundbreaking research and novel therapeutic solutions in their field.
Conclusion
With a commendable array of patents and a strong professional background, Jennifer X Qiao continues to be a pioneer in the field of pharmacological innovations. Her work not only enhances the scientific community's knowledge but also promises to improve patient outcomes in the years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile